The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
neomycin and polymyxin b sulfates · Solution
2 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Aminoglycoside Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- bacitracin· in shortage
- amikacin· 1 maker
- antibiotic pain relief· 1 maker
- bacitracin zin, neomycin sulfate, polymyxin b sulfate· 1 maker
- bacitracin zinc 400 u, polymxyin b sulfate 5,000 u, neomycin sulfate 3.5mg/g· 1 maker
- bacitracin zinc and neomycin and polymyxin b sulfate· 1 maker
- bacitracin zinc neomycin sulfate polymyxin b sulfate pramoxine hcl· 1 maker
- bacitracin zinc, neomycin and polymyxin b sulfate· 1 maker
- bacitracin zinc, neomycin sulfate , polymyxin b sulfate, lidocaine· 1 maker
- bacitracin zinc, neomycin sulfate and polymyxin b sulfate· 1 maker
- bacitracin zinc, neomycin sulfate, and polymyxin b· 1 maker
- bacitracin zinc, neomycin sulfate, polymyxin b· 1 maker
Common questions
- Is Neomycin and polymyxin b sulfates in shortage right now?
- No. FDA does not currently list Neomycin and polymyxin b sulfates in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Neomycin and polymyxin b sulfates?
- 1 company has marketed Neomycin and polymyxin b sulfates in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.